FEM:NASDAQFirst Trust Emerging Markets AlphaDEX Fund Analysis

The First Trust Emerging Markets AlphaDEX Fund (FEM) is trading at $30.25, comfortably above its 20‑day ($29.75) and 200‑day ($27.40) simple moving averages, and just north of the 50‑day SMA ($30.11), suggesting short‑term strength. Technical momentum is reinforced by a bullish MACD crossover (histogram positive) and a neutral‑to‑bullish RSI at 54, while daily volume is on an upward trend, supporting price advances. Valuation appears attractive with a dividend yield of 2.73% and a modest beta of 0.69, indicating lower volatility relative to broader markets, though the fund’s 30‑day volatility sits at a high 26% and the maximum drawdown of roughly 12% signals potential downside risk. The expense ratio of 0.80% is above the industry average, which could erode returns over time, but the fund benefits from a zero tracking error and no premium/discount to NAV. Market sentiment is exuberant, as reflected by an “Extreme Greed” reading of 78.8 on the Fear & Greed Index, implying that price momentum may be partially driven by broader risk‑on behavior.
Given the lack of any material news specific to FEM, the outlook relies primarily on these quantitative signals. The fund’s diversified emerging‑market exposure offers growth potential, yet investors should monitor the elevated volatility and expense drag. A balanced approach—holding through short‑term fluctuations while positioning for medium‑term upside—appears prudent, with a watchful eye on any shifts in market sentiment or emerging‑market fundamentals.